Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/55790
Title: Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis.
Authors: 
Keywords: 
Issue Date: 17-Jun-2021
Citation: BMJ Nutr Prev Health.2021;(4)1:285-292
Abstract: Smoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established. We included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included following an in-hospital admission with a COVID-19 diagnosis. We analysed the outcomes of patients with a current or prior history of smoking compared with the non-smoking group. The primary endpoint was all-cause in-hospital death. Finally, 5224 patients with COVID-19 with available smoking status were analysed. A total of 3983 (67.9%) patients were non-smokers, 934 (15.9%) were former smokers and 307 (5.2%) were active smokers. The median age was 66 years (IQR 52.0-77.0) and 58.6% were male. The most frequent comorbidities were hypertension (48.5%) and dyslipidaemia (33.0%). A relevant lung disease was present in 19.4%. In-hospital complications such sepsis (23.6%) and embolic events (4.3%) occurred more frequently in the smoker group (p Smoking has a negative prognostic impact on patients hospitalised with COVID-19.
PMID: 34308137
URI: https://hdl.handle.net/20.500.12530/55790
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > FIIB H. U. Infanta Sofía y H. U. Henares > Artículos

Files in This Item:
File SizeFormat 
PMC8214987.pdf634.18 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons